VASCULAR DYSFUNCTION IN THE Α-GALACTOSIDASE A-KNOCKOUT MOUSE IS AN ENDOTHELIAL CELL-, PLASMA MEMBRANE-BASED DEFECT
dc.contributor.author | Park, James L. | en_US |
dc.contributor.author | Whitesall, Steven E. | en_US |
dc.contributor.author | D’alecy, Louis G. | en_US |
dc.contributor.author | Shu, Liming | en_US |
dc.contributor.author | Shayman, James A. | en_US |
dc.date.accessioned | 2010-06-01T22:09:20Z | |
dc.date.available | 2010-06-01T22:09:20Z | |
dc.date.issued | 2008-10 | en_US |
dc.identifier.citation | Park, James L; Whitesall, Steven E; D’Alecy, Louis G; Shu, Liming; Shayman, James A (2008). "VASCULAR DYSFUNCTION IN THE Α-GALACTOSIDASE A-KNOCKOUT MOUSE IS AN ENDOTHELIAL CELL-, PLASMA MEMBRANE-BASED DEFECT." Clinical and Experimental Pharmacology and Physiology 35(10): 1156-1163. <http://hdl.handle.net/2027.42/75176> | en_US |
dc.identifier.issn | 0305-1870 | en_US |
dc.identifier.issn | 1440-1681 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/75176 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18565198&dopt=citation | en_US |
dc.format.extent | 477881 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Asia | en_US |
dc.rights | © 2008 Blackwell Publishing Asia Pty Ltd | en_US |
dc.subject.other | Endothelium | en_US |
dc.subject.other | Fabry Disease | en_US |
dc.subject.other | Α-Galactosidase A | en_US |
dc.subject.other | Globotriaosylceramide | en_US |
dc.title | VASCULAR DYSFUNCTION IN THE Α-GALACTOSIDASE A-KNOCKOUT MOUSE IS AN ENDOTHELIAL CELL-, PLASMA MEMBRANE-BASED DEFECT | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbsecondlevel | Physiology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | * Division of Nephrology, Department of Internal Medicine, University of Michigan Medical Center, | en_US |
dc.contributor.affiliationum | Department of Surgery, University of Michigan Medical School, Ann Arbor and | en_US |
dc.contributor.affiliationum | Department of Surgery, William Beaumont Hospital, Royal Oak, Michigan, USA | en_US |
dc.contributor.affiliationother | Department of Molecular and Integrative Physiology, | en_US |
dc.identifier.pmid | 18565198 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/75176/1/j.1440-1681.2008.04984.x.pdf | |
dc.identifier.doi | 10.1111/j.1440-1681.2008.04984.x | en_US |
dc.identifier.source | Clinical and Experimental Pharmacology and Physiology | en_US |
dc.identifier.citedreference | Kint JA. The enzyme defect in Fabry's disease. Nature 1970; 227: 1173. | en_US |
dc.identifier.citedreference | Kint JA. Fabry's disease: Alpha-galactosidase deficiency. Science 1970; 167: 1268 – 9. | en_US |
dc.identifier.citedreference | Sweeley CC, Klionsky B. Fabry's disease: Classification as a sphingolipidosis and partial characterization of a novel glycolipid. J. Biol. Chem. 1963; 238: 3148 – 50. | en_US |
dc.identifier.citedreference | Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. N. Engl. J. Med. 1967; 276: 1163 – 7. | en_US |
dc.identifier.citedreference | Desnick RJ, Ioannou YA, Eng CM. Α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic and Molecular Bases of Inherited Disease, 8th edn. McGraw-Hill, New York. 2001; 3733 – 74. | en_US |
dc.identifier.citedreference | Desnick RJ, Banikazemi M, Wasserstein M. Enzyme replacement therapy for Fabry disease, an inherited nephropathy. Clin. Nephrol. 2002; 57: 1 – 8. | en_US |
dc.identifier.citedreference | Eitzman DT, Bodary PF, Shen Y et al. Fabry disease in mice is associated with age-dependent susceptibility to vascular thrombosis. J. Am. Soc. Nephrol. 2003; 14: 298 – 302. | en_US |
dc.identifier.citedreference | Shu L, Murphy HS, Cooling L, Shayman JA. An in vitro model of Fabry disease. J. Am. Soc. Nephrol. 2005; 16: 2636 – 45. | en_US |
dc.identifier.citedreference | Ohshima T, Murray GJ, Swaim WD et al. Alpha-Galactosidase A deficient mice: A model of Fabry disease. Proc. Natl Acad. Sci. USA 1997; 94: 2540 – 4. | en_US |
dc.identifier.citedreference | Shen Y, Bodary PF, Vargas FB et al. Alpha-galactosidase A deficiency leads to increased tissue fibrin deposition and thrombosis in mice homozygous for the factor V Leiden mutation. Stroke 2006; 37: 1106 – 8. | en_US |
dc.identifier.citedreference | Bodary PF, Shen Y, Vargas FB et al. Alpha-galactosidase A deficiency accelerates atherosclerosis in mice with apolipoprotein E deficiency. Circulation 2005; 111: 629 – 32. | en_US |
dc.identifier.citedreference | Moore DF, Gelderman MP, Fuhrmann SR, Schiffmann R, Brady RO, Goldin E. Fabry disease and vascular risk factors: Future strategies for patient-based studies and the knockout murine model. Acta Paediatr. Suppl. 2006; 95: 69 – 71. | en_US |
dc.identifier.citedreference | Heare T, Alp NJ, Priestman DA et al. Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease: Partial prevention by N -butyldeoxynojirimycin treatment. J. Inherit. Metab. Dis. 2007; 30: 79 – 87. | en_US |
dc.identifier.citedreference | Whitesall SE, Hoff JB, Vollmer AP, D’Alecy LG. Comparison of simultaneous measurement of mouse systolic arterial blood pressure by radiotelemetry and tail-cuff methods. Am. J. Physiol. Heart Circ. Physiol. 2004; 286: H2408 – 15. | en_US |
dc.identifier.citedreference | Tang EH, Ku DD, Tipoe GL, Feletou M, Man RY, Vanhoutte PM. Endothelium-dependent contractions occur in the aorta of wild-type and COX2 −/– knockout but not COX1 −/– knockout mice. J. Cardiovasc. Pharmacol. 2005; 46: 761 – 5. | en_US |
dc.identifier.citedreference | Faraci FM, Sigmund CD, Shesely EG, Maeda N, Heistad DD. Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am. J. Physiol. 1998; 274: H564 – 70. | en_US |
dc.identifier.citedreference | Park JL, Loberg RD, Duquaine D et al. GLUT4 facilitative glucose transporter specifically and differentially contributes to agonist-induced vascular reactivity in mouse aorta. Arterioscler. Thromb. Vasc. Biol. 2005; 25: 1596 – 602. | en_US |
dc.identifier.citedreference | Tang EH, Feletou M, Huang Y, Man RY, Vanhoutte PM. Acetylcholine and sodium nitroprusside cause long-term inhibition of EDCF-mediated contractions. Am. J. Physiol. Heart Circ. Physiol. 2005; 289: H2434 – 40. | en_US |
dc.identifier.citedreference | Zhou Y, Varadharaj S, Zhao X, Parinandi N, Flavahan NA, Zweier JL. Acetylcholine causes endothelium-dependent contraction of mouse arteries. Am. J. Physiol. Heart Circ. Physiol. 2005; 289: H1027 – 32. | en_US |
dc.identifier.citedreference | Shayman JA, Killen PD. Fabry disease. In: Mount DB, Pollak MJ (eds). Molecular and Genetic Basis of Renal Disease. Saunders / Elsevier, Philadelphia. 2008; Ch. 13. | en_US |
dc.identifier.citedreference | Elliott PM, Kindler H, Shah JS et al. Coronary microvascular dysfunction in male patients with Anderson–Fabry disease and the effect of treatment with alpha galactosidase A. Heart 2006; 92: 357 – 60. | en_US |
dc.identifier.citedreference | Moore DF, Kaneski CR, Askari H, Schiffmann R. The cerebral vasculopathy of Fabry disease. J. Neurol. Sci. 2007; 257: 258 – 63. | en_US |
dc.identifier.citedreference | Guo Z, Su W, Allen S et al. COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice. Cardiovasc. Res. 2005; 67: 723 – 35. | en_US |
dc.identifier.citedreference | Linder AE, Weber DS, Whitesall SE, D’Alecy LG, Webb RC. Altered vascular reactivity in mice made hypertensive by nitric oxide synthase inhibition. J. Cardiovasc. Pharmacol. 2005; 46: 438 – 44. | en_US |
dc.identifier.citedreference | Pannirselvam M, Verma S, Anderson TJ, Triggle CR. Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db −/– ) mice: Role of decreased tetrahydrobiopterin bioavailability. Br. J. Pharmacol. 2002; 136: 255 – 63. | en_US |
dc.identifier.citedreference | Pannirselvam M, Wiehler WB, Anderson T, Triggle CR. Enhanced vascular reactivity of small mesenteric arteries from diabetic mice is associated with enhanced oxidative stress and cyclooxygenase products. Br. J. Pharmacol. 2005; 144: 953 – 60. | en_US |
dc.identifier.citedreference | Shepherd JT, Katusic ZS. Endothelium-derived vasoactive factors. I. Endothelium-dependent relaxation. Hypertension 1991; 18 ( Suppl. III ): III - 76 – 85. | en_US |
dc.identifier.citedreference | Shu L, Shayman JA. Caveolin-associated accumulation of globotriaosylceramide in the vascular endothelium of alpha-galactosidase A null mice. J. Biol. Chem. 2007; 282: 20 960 – 7. | en_US |
dc.identifier.citedreference | Shu L, Lee L, Shayman JA. Regulation of phospholipase C-gamma activity by glycosphingolipids. J. Biol. Chem. 2002; 277: 18 447 – 53. | en_US |
dc.identifier.citedreference | Shu L, Shayman JA. Src kinase mediates the regulation of phospholipase C-gamma activity by glycosphingolipids. J. Biol. Chem. 2003; 278: 31 419 – 25. | en_US |
dc.identifier.citedreference | Brown DA, London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 2000; 275: 17 221 – 4. | en_US |
dc.identifier.citedreference | Vanhoutte PM, Feletou M, Taddei S. Endothelium-dependent contractions in hypertension. Br. J. Pharmacol. 2005; 144: 449 – 58. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.